国庆请假休29天

连山区税务局 精准释放涉农税惠红利 助力企业可持续发展_我的网站

一 |     (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed.    China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval.    A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country.    Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category.    This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading.     At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly.    To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong.    The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions.    In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total.        (By Tang Yuxian)                    。    本报讯 张唯 记者刘波报道 4座鸡舍、蛋鸡养殖规模10万羽、日产蛋量8000余斤，4名工人承担全部养殖工作，现代化养殖场节省出大量人力资源。连山区富兴养殖场坐落于新台门镇哑鹿沟村，曾经的贫困地区如今也开起了规模颇大的现代化养殖场。

二 | 近日，连山区税务局精准释放涉农税惠红利，组建青年助农小分队精准对接“鸡司令”，促进农村“土”资源持续发展，助力乡村产业振兴。         　　数列高大规整的养殖笼纵深近百米，每列养殖笼对应的传送带“各司其职”、“井然有序”，暖黄色的灯光充盈着整个厂房，4名女工不慌不忙地将传送带上的鸡蛋拾起、装箱。走进富兴养殖场，目之所及无不散发科技的气息，这座位于村屯深处的养殖场给税务干部带来了不小的视觉震撼。“2020年我们建立第一个新养殖场，购置了智能养殖系统和设备。”企业负责人张女士向税务干部介绍道，“现在4个鸡舍都实现了全自动配料喂粮、保温和粪便收集，这些工作，在几年前的旧厂房里只能依靠人工，费时费力不说，还不环保。”小分队了解到，富兴养殖场主要与生鲜超市和大蛋商合作，向新台门镇和杨家杖子地区供应优质鸡蛋。通过封闭式机械化管理，一方面，在保证产蛋数量和质量的前提下，养殖场实现了人力物力资源高效配置，提高利润；另一方面，室内温度、湿度适宜可控，能够有效避免天气原因引发的病害损耗。目前，富兴养殖场已经形成产蛋、肉食、粪肥出售的纯绿色产业链，实现科技化、生态化、可持续发展的产业转型。“企业能有现在的发展离不开税务政策的一路支持。”张女士表示，“近些年来养殖场扩建，税务干部辅导我们享受了牲畜、家禽饲养免征、减免等政策。充裕的资金流继续投入到生产经营中，让企业转型升级、延伸产业链都更有底气。

三 | ”走访过程中，小分队根据企业具体生产经营情况，为企业梳理最新涉农税费减免政策，帮助企业“健康体检”，送上暖心税费政策大礼包。

Current article:http://oml8v4.dinggaxilianmaiyuejienianguai.shop/list_azzuh5n/xast.html

Published on:16:05:26